Outset Medical, Inc. Payments for Operating Activities
Outset Medical, Inc. (OM) reported Payments for Operating Activities of $22.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:PaymentsForOperatingActivities · last filed 2026-08-06
- Outset Medical, Inc. payments for operating activities for the quarter ending 2026-06-30 was $9.70M, a 102.08% increase year-over-year.
- Outset Medical, Inc. payments for operating activities for the quarter ending 2026-03-31 was $12.80M, a 50.19% decline year-over-year.
- Outset Medical, Inc. payments for operating activities for the quarter ending 2025-12-31 was $9.50M, a 42.42% decline year-over-year.
- Outset Medical, Inc. payments for operating activities for the quarter ending 2025-09-30 was $6.30M.
- Outset Medical, Inc. payments for operating activities for fiscal 2025 was $46.30M, a 60.19% decline from fiscal 2024.
- Outset Medical, Inc. payments for operating activities for fiscal 2024 was $116.30M, a 11.49% decline from fiscal 2023.
- Outset Medical, Inc. payments for operating activities for fiscal 2023 was $131.40M.
| Period end | Payments for Operating Activities 3 month | Payments for Operating Activities 6 month | Payments for Operating Activities 9 month | Payments for Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $22.50M 10-Q · filed 2026-08-06 | $32.00M derived: sum of 3 quarters · filed 2026-08-06 | $38.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $12.80M 10-Q · filed 2026-05-07 | $22.30M derived: sum of 2 quarters · filed 2026-05-07 | $28.60M derived: sum of 3 quarters · filed 2026-05-07 | $33.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $15.80M derived: sum of 2 quarters · filed 2026-02-13 | $20.60M derived: sum of 3 quarters · filed 2026-08-06 | $46.30M 10-K · filed 2026-02-13 |
| 2025-09-30 | $6.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $11.10M derived: sum of 2 quarters · filed 2026-08-06 | $36.80M 10-Q · filed 2025-11-10 | $53.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $30.50M 10-Q · filed 2026-08-06 | $47.00M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-03-31 | $25.70M 10-Q · filed 2026-05-07 | $42.20M derived: sum of 2 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $16.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $116.30M 10-K · filed 2026-02-13 | ||
| 2024-09-30 | $99.80M 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | $24.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $131.40M 10-K · filed 2026-02-13 | ||
| 2023-09-30 | $106.90M 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |